Abstract
Objective To analyze the prevalence and distribution characteristics of dyslipidemia in adult residents of Xinjiang Uygur Autonomous Region (Xinjiang), and to provide effective prevention and control measures for dyslipidemia.
Methods In 2018, a total of 4865 permanent residents aged 18 years and above were investigated by multi-stage stratified cluster random sampling in 8 monitoring counties (cities and districts) in Xinjiang. Questionnaire survey and laboratory tests were conducted, and fasting venous blood was collected to detect the levels of TC, TG, HDL-C and LDL-C in serum. To analyze the difference of the detection results of relevant indexes in serum of different age, sex and urban and rural adults.
Results The prevalence of dyslipidemia in adults in Xinjiang was 48.35%, among which the prevalence of hypercholesterolemia(high TC), hypertriglyceridemia(high TG), high low-density lipoprotein cholesterol(high LDL-C) and low high-density lipoprotein cholesterol (low HDL-C)were 18.58%, 28.04%, 25.30% and 13.40%. In 2018, the serum TC level in Xinjiang adults was (4.46±0.91) mmol/L, and that in males and females was (4.42±0.89) and (4.49±0.92) mmol/L, respectively (t=-2.848, p < 0.05). The serum TC level of urban residents (4.57±0.93) mmol/L was higher than that of rural residents (4.38±0.89) mmol/L, and the difference was statistically significant (t=6.979, p < 0.001). The difference of serum TC levels in different age groups was statistically significant (F=199.389, p < 0.001). The serum TG level was (1.52±1.12) mmol/L, (1.64±1.31) in male and (1.43±0.93) mmol/L in female, (t=6.359, p < 0.001). The serum TG level of urban residents (1.66±1.33) mmol/L was higher than that of rural residents (1.43±0.94) mmol/L, and the difference was statistically significant (t=7.088, p < 0.001). There were significant differences in serum TG levels among different age groups (F=31.355, p < 0.001). Serum HDL-C level was (1.23±0.33) mmol/L, (1.14±0.32) in male and (1.29±0.33) mmol/L in female, (t=-16.033, p < 0.001). The serum HDL-C level of urban residents (1.25±0.34 mmol/L) was higher than that of rural residents (1.21±0.33 mmol/L), and the difference was statistically significant (t=4.298, p < 0.001). The difference of serum HDL-C level in different age groups was statistically significant (F=10.992, p < 0.001). Serum LDL-C level was (2.55±0.77) mmol/L, (2.54±0.76) in male and (2.55±0.78) mmol/L in female, (t=-0.426, p > 0.05). The serum LDL-C level of urban residents (2.58±0.82) mmol/L was higher than that of rural residents (2.53±0.74) mmol/L, and the difference was statistically significant (t=2.180, p < 0.05). There were significant differences in serum LDL-C levels among different age groups (F=121.679, p < 0.001).
Conclusion The prevalence of dyslipidemia in adults in Xinjiang is higher than the national level, the serum LDL-C level in men is lower than that in women, and the serum TC, TG and HDL-C levels are higher than that in women.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
N/A
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The project was reviewed by the Ethics Review Committee of the Chinese Center for Disease Control and Prevention (CDC), and all investigation subjects signed informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos